Simplex Trading’s Kronos Bio KRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,957
Closed -$2K 9231
2025
Q1
$2K Buy
+2,957
New +$2.85K ﹤0.01% 8007
2024
Q4
Sell
-149
Closed 9107
2024
Q3
$0 Sell
149
-1,881
-93% -$2.08K ﹤0.01% 9051
2024
Q2
$2K Sell
2,030
-3,160
-61% -$3.22K ﹤0.01% 8296
2024
Q1
$6K Buy
5,190
+4,499
+651% +$5.13K ﹤0.01% 7922
2023
Q4
$0 Buy
+691
New +$765 ﹤0.01% 9350
2022
Q2
Sell
-238
Closed -$1.08K 10541
2022
Q1
$1K Buy
+238
New +$2.03K ﹤0.01% 10093
2021
Q4
Sell
-98
Closed -$2K 10947
2021
Q3
$2K Hold
98
﹤0.01% 9537
2021
Q2
$2K Buy
+98
New +$2.48K ﹤0.01% 9719

Simplex Trading's KRON Position: Q2 2025 in Review

Simplex Trading sold out of Kronos Bio (KRON) in Q2 2025, closing a stake of 2,957 shares — an estimated $2K sold.

Simplex Trading first reported a position in KRON in Q2 2021 and held it in 8 quarters. The position peaked at $6K in Q1 2024. 0 funds tracked by Wall St. Rank hold KRON as of Q2 2025.

  • Simplex Trading reported no remaining Kronos Bio position as of Q2 2025 after selling out during the quarter.
  • Simplex Trading sold 2,957 Kronos Bio shares in Q2 2025, an estimated $2K.
  • Simplex Trading first reported a position in Kronos Bio in Q2 2021 and held it in 8 quarters.
  • Simplex Trading's Kronos Bio position peaked at $6K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.